n-(Furan-2-ylmethyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide, 98%, 1g

2-(3-Benzoylthioureido)-5,5-dimethyl-5,7-dihydro-4H-thieno[2,3-c]pyran-3-carboxylic acid, 97.0%, 5mg

1-(4-Methoxypyrimidin-2-yl)piperidine-4-carboxylic acid, 98%, 250mg

(5-Methyl-3-phenyl-1H-pyrazol-1-yl)methanol, 95.0%, 5g

(4-(Bromomethyl)phenyl)(cyclopropyl)methanone, 95.0%, 1g

Ethyl 4,6-dichloro-2-methylnicotinate, 95.0%, 5g

8-(2-Methoxyphenyl)-8-oxooctanoic acid, 97.0%, 1g

3,6,9-Trioxo-1-phenyl-2-oxa-4,7,10-triazadodecan-12-oic acid, 95.0%, 5g

2-Ethylhexanoic acid 250mL, >=99%, for synthesis, 250mL, glass packaging

2-Methyl-4-(trifluoromethyl)phenol, 98%, 1g

1,2-Benzisothiazol-3(2H)-one>98.0%(GC)25g

4-N-Phthaloylglyaminomethyl aniline, 98.0%, 5g

25-Iodo-2,5,8,11,14,17,20,23-octaoxapentacosane, 95%, 1g